BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21092835)

  • 1. Randomized comparison of whole brain radiotherapy, 20 Gy in four daily fractions versus 40 Gy in 20 twice-daily fractions, for brain metastases. In regard to Graham et al. (Int J Radiat Oncol Biol Phys 2010;77(3):648-54.).
    Davey P; Smith J; Ennis M
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1605-6; author reply 1606. PubMed ID: 21092835
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized comparison of whole brain radiotherapy, 20 Gy in four daily fractions versus 40 Gy in 20 twice-daily fractions, for brain metastases.
    Graham PH; Bucci J; Browne L
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):648-54. PubMed ID: 19836153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant whole brain radiotherapy: strong emotions decide but rationale studies are needed: in regard to Brown et al. (Int J Radiat Oncol Biol Phys 2008;70:1305-1309). In reply to Drs. Larson and Sahgal.
    Brown PD; Kee AY; Eshleman JS; Fiveash JB
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):316-7. PubMed ID: 19695444
    [No Abstract]   [Full Text] [Related]  

  • 4. Hippocampal-sparing whole-brain radiotherapy: a "how-to" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy: in regard to Gondi v, et al. (Int j radiat oncol biol phys 2010;78:1244-1252).
    Knisely JP; Yu JB
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):957-8; author reply 958. PubMed ID: 21281899
    [No Abstract]   [Full Text] [Related]  

  • 5. Simultaneous in-field boost for brain metastases: in regard to Lagerwaard et al. (Int J Radiat Oncol Biol Phys 2009;75:253-259).
    Hallock A; Bauman G; Chen J; Yartsev S
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):964-5; author reply 965. PubMed ID: 20869584
    [No Abstract]   [Full Text] [Related]  

  • 6. Cognitive function before and after whole brain radiotherapy: in regard to Welzel et al. (Int J Radiat Oncol Biol Phys 2008;72:1311-1318).
    Liao XB; Qiu XY; Yan SX
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):975; author reply 975-6. PubMed ID: 19480978
    [No Abstract]   [Full Text] [Related]  

  • 7. The importance of radiotherapy in AT/RT patients less than 3 years of age: in regards to Chen et al. (Int J Radiat Oncol Biol Phys 2006;64:1038-1043).
    Stadler P; Peters O
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1273; author reply 1273-4. PubMed ID: 16798419
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
    Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
    Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal treatment for intracranial germinoma: can we lower, radiation dose without chemotherapy? In regard to Yen S-H et al. (Int J Radiat Oncol Biol Phys Epub October 27, 2009).
    Lavey RS; Olch AJ
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):638-9; author reply 639. PubMed ID: 20457356
    [No Abstract]   [Full Text] [Related]  

  • 10. Do patients receiving whole-brain radiotherapy for brain metastases from renal cell carcinoma benefit from escalation of the radiation dose?
    Rades D; Heisterkamp C; Schild SE
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):398-403. PubMed ID: 20488627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in multifocal gliomas: in regard to Showalter et al. (Int J Radiat Oncol Biol Phys 2007;69:820-824).
    Kyritsis AP; Rao JS; Puduvalli VK
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1335; author reply 1335. PubMed ID: 17967325
    [No Abstract]   [Full Text] [Related]  

  • 12. Delayed effects of whole brain radiotherapy in germ cell tumor patients with central nervous system metastases.
    Doyle DM; Einhorn LH
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1361-4. PubMed ID: 18374223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of chemotherapy for brain metastases from breast carcinoma: in regard to Le Scodan et al. (Int J Radiat Oncol Biol Phys 2007;69:839-845).
    Dizdar O; Harputluoglu H; Tapan U; Altundag K
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1615. PubMed ID: 18374237
    [No Abstract]   [Full Text] [Related]  

  • 14. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
    Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integral radiation dose to normal structures with conformal external beam radiation: in regards to Aoyama et al. (Int J Radiat Oncol Biol Phys 2006;64:962-967).
    Peñagarícano JA
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1274; author reply 1274-5. PubMed ID: 16798421
    [No Abstract]   [Full Text] [Related]  

  • 16. In regard to Miller et al.: Multiple sclerosis, brain radiotherapy and risk of neurotoxicity: the Mayo Clinic experience (Int J Radiat Oncol Biol Phys 2006;66:1178-1186).
    Sriram S
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):960-1; author reply 961. PubMed ID: 17544007
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant whole brain radiotherapy: strong emotions decide but rationale studies are needed: in regard to Brown et al. (Int J Radiat Oncol Biol Phys 2008;70:1305-1309).
    Larson D; Sahgal A
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):959. PubMed ID: 19014787
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose escalation of whole-brain radiotherapy for brain metastases from melanoma.
    Rades D; Heisterkamp C; Huttenlocher S; Bohlen G; Dunst J; Haatanen T; Schild SE
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):537-41. PubMed ID: 19733017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
    Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
    Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In regards to Miller et al.: Multiple sclerosis, brain radiotherapy, and risk of recurrence: the Mayo Clinic Experience (Int J Radiat Oncol Biol Phys 2006;66:1178-1186).
    Khandelwal SR
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):955; author reply 955. PubMed ID: 17293244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.